A multi-center phase II study of sequential paclitaxel and bryostatin-1 (NSC 339555) in patients with untreated, advanced gastric or gastroesophageal junction adenocarcinoma

Author: Ajani Jaffer   Jiang Yixing   Faust Josephine   Chang Baochong   Ho Linus   Yao James   Rousey Steven   Dakhil Shaker   Cherny Richard   Craig Catherine   Bleyer Archie  

Publisher: Springer Publishing Company

ISSN: 0167-6997

Source: Investigational New Drugs, Vol.24, Iss.4, 2006-07, pp. : 353-357

Disclaimer: Any content in publications that violate the sovereignty, the constitution or regulations of the PRC is not accepted or approved by CNPIEC.

Previous Menu Next

Abstract

Related content